EUCTR2004-004990-27-IT进行中（未招募）不适用
The pharmacokinetic interaction between TMC114, lopinavir and ritonavir, in HIV-1 infected subjects.
TIBOTEC PHARMACEUTICALS LTD.0 个研究点目标入组 32 人开始时间: 2005年7月26日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
1 期
Drug-drug interaction study with TS-142 in healthy adult subjects (concomitant administration of itraconazole)InsomniaJPRN-jRCT2071200036Mita Seiji10
已完成
2 期
Study on the pharmacokinetic interaction between cabazitaxel and darolutamide in metastatic castration-resistant prostate cancer (mCRPC) patients.Metastatic castration-resistant prostate cancer10038597NL-OMON50053Erasmus MC, Universitair Medisch Centrum Rotterdam20
已完成
不适用
Study on the pharmacokinetic interaction between cabazitaxel and darolutamide in metastatic castration-resistant prostate cancer (mCRPC) patients.NL-OMON28448Erasmus MC17
进行中（未招募）
1 期
Study on the interaction between cabazitaxel and darolutamide in patients with metastatic prostate cancermetastatic castration-resistant prostate cancerEUCTR2020-000823-38-NLErasmus MC Cancer Institute17
进行中（未招募）
1 期
A pharmacokinetic study of TS-142 in patients with hepatic impairmentInsomniaJPRN-jRCT2031220463Mita Seiji24